Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Funahashi, A
Right arrow Articles by Hranicka, L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Funahashi, A
Right arrow Articles by Hranicka, L.

Chest, Vol 76, 514-517, Copyright © 1979 by American College of Chest Physicians

ARTICLES

Diagnostic value of bronchial aspirate and postbronchoscopic sputum in fiberoptic bronchoscopy

A Funahashi, TK Browne, WC Houser and LJ Hranicka

The contribution of the bronchial aspirate and postbronchoscopic sputum toward the establishment of a correct diagnosis of bronchogenic carcinoma was evaluated. A total of 273 patients underwent diagnostic bronchoscopic procedures during a 27-month period. One hundred four of these 273 patients were eventually found to have bronchogenic carcinoma. The combination of biopsies by forceps and brushings yielded the diagnosis in 61 (97 percent) of 63 endoscopically visible tumors. Neither bronchial aspirates nor postbronchoscopic specimens of sputum produced an additional diagnosis. The same combination yielded a diagnosis in 17 (41 percent) of 41 endoscopically nonvisible tumors. In these endoscopically nonvisible tumors, unlike tumors, a combination of bronchial aspirates and postbronchoscopic specimens of sputum produced a total of eight additional diagnosis. Thus, the overall diagnosis of endoscopically nonvisible tumors was improved from 41 percent (17/41) to 61 percent (25/41). Both bronchial aspirates and postbronchoscopic specimens of sputum were therefore important sources of diagnosis in endoscopically nonvisible tumors.


This article has been cited by other articles:


Home page
 ChestHome page
J. Blum, H. Handmaker, J. Lister-James, and N. Rinne
A Multicenter Trial With a Somatostatin Analog 99mTc Depreotide in the Evaluation of Solitary Pulmonary Nodules
Chest, May 1, 2000; 117(5): 1232 - 1238.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1979 by the American College of Chest Physicians.